Clinical Trial Update: The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial entry evaluating diclofenac sodium as an intracanal medicament in endodontic conditions; phases 2 and 3, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endodontic Disease
• Pulpitis

Drugs mentioned

• DICLOFENAC SODIUM (DICLOFENAC SODIUM)

Snippet

Sponsor: British University In Egypt | Conditions: Endodontic Disease, Pulp Disease, Dental | Phase 2, Phase 3 | Status: RECRUITING